(+)-1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(2-HYDROXY-1S-METHYLETHYL)-UREA
Compound with spectra: 1 NMR
![(+)-1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(2-HYDROXY-1S-METHYLETHYL)-UREA](/api/compound/1b7eBgDWDF1.png?ph=true&h=300&w=458 "(+)-1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(2-HYDROXY-1S-METHYLETHYL)-UREA")
| SpectraBase Compound ID | 1b7eBgDWDF1 |
|---|---|
| InChI | InChI=1S/C20H24ClN3O6S2/c1-13(12-25)31-23-20(27)24-32(28,29)16-6-3-14(4-7-16)9-10-22-19(26)17-11-15(21)5-8-18(17)30-2/h3-8,11,13,25H,9-10,12H2,1-2H3,(H,22,26)(H2,23,24,27)/t13-/m0/s1 |
| InChIKey | VGKUWLIMSYEZBG-ZDUSSCGKSA-N |
| Mol Weight | 502.0 g/mol |
| Molecular Formula | C20H24ClN3O6S2 |
| Exact Mass | 501.079506 g/mol |
| Enantiomer InChIKey | VGKUWLIMSYEZBG-CYBMUJFWSA-N |
| Racemate InChIKey | VGKUWLIMSYEZBG-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(3-HYDROXYPROPYL)-UREA
1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(2-HYDROXYETHYL)-UREA
1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(4-HYDROXYBUTYL)-UREA
1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(5-HYDROXYPENTYL)-UREA
5-Chloranyl-N-[[4-(ethanoylsulfamoyl)phenyl]carbamothioyl]-2-methoxy-benzamide
5-chloro-2-methoxy-N-(4-{[(4-methylphenyl)sulfonyl]amino}phenyl)benzamide
2-Methoxy-4-(methylsulfanyl)-N-{2-[4-(1-pyrrolidinylsulfonyl)phenyl]ethyl}benzamide
TAIWANAMIDE-C
N-(1)-{[4'-(2''-Thienyl)methylenecarbonyl]phenyl}-5-chloro-2-methoxybenzamide
5-chloro-N-[5-(ethylsulfanyl)-1,3,4-thiadiazol-2-yl]-2-methoxybenzamide
| Title | Journal or Book | Year |
|---|---|---|
| Hydroxyl-Substituted sulfonylureas as potent inhibitors of specific [3H]Glyburide binding to rat brain synaptosomes | Bioorganic & Medicinal Chemistry | 2003 |